Press-release for stocks for imab

Prices are updated after-hours

I-Mab’s Antibody for Severe COVID-19 Looks Good in Interim Analysis
Published: 2021-08-11 (Crawled : 18:00) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K

| -97.7% | O: -6.04% H: 0.27% C: -2.71%
covid antibody covid-19

| -97.7% | O: -6.04% H: 0.27% C: -2.71%
covid phase 2 phase 2/3 positive antibody

65%

35%

CSSE 4 | $0.4323 183.85% 64.77% 210M

BOF | $1.99 70.09% 41.21% 110M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

ILAG | $0.51 6.03% 29.06% 430K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.